Skip to main content
logo
Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
19.18
-0.07 (-0.36%)
At close: Oct 16, 2026, 4:00 PM EDT
19.75
+0.57 (2.95%)
After-hours: Oct 16, 2026, 7:30 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Net Revenue
1.81B1.75B1.69B
Specialty Net Revenue
574.73M528.51M445.75M
AvKARE Net Revenue
732.28M744.73M662.95M
Revenue (Total)
3.12B3.02B2.79B

Gross Profit

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Gross Profit
729.09M683.92M673.90M
Specialty Gross Profit
346.41M282.59M242.93M
AvKARE Gross Profit
150.29M146.79M103.61M
Gross Profit (Total)
1.23B1.11B1.02B

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Affordable Medicines Operating Income
411.65M380.80M270.10M
Specialty Operating Income
170.44M116.00M113.58M
AvKARE Operating Income
84.29M83.62M42.90M
Corporate and Other Operating Income
-212.46M-186.32M-177.26M
Operating Income (Total)
453.92M394.10M249.33M